Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced that it has received notification from its licensing ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Diagnosed in 2012 with prostate cancer, Tony Minter says his purpose is to share his journey with others. Now in remission, he leads a support group for men newly diagnosed and serves on the board of ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Pooled trials show Pluvicto improves progression-free survival in advanced prostate cancer, without increasing serious adverse events. An examination of data from more than 2500 patients with advanced ...

Prostate cancer numbers are down, except for men in one group: those with advanced prostate cancer. What’s behind the rise in these cases?

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the ...

Eric Forrest, best known for his time with Voivod and his ongoing work fronting E-Force, has gone public with his battle against prostate cancer. Earlier today, the Toulouse, France–based vocalist and ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

RIYADH, SAUDI ARABIA, February 24, 2026 /EINPresswire.com/ — King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a ...